Clinical Trials · NCT01377389
Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 30
- Start date
- Jun 2011
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants Who Progressed After 7 Months of Being on Treatment